A preclinical model for experimental chemotherapy of human head and neck cancer.

International journal of oncology

Volumn 18, Issue 6, 2001, Pages 1145-1149

  Sommer, K ^a   Peters, S O ^a   Robins, I H ^a   Raap, M ^a   Wiedemann, G J ^a   Remmert, S ^a   Sieg, P ^a   Bittner, C ^a   Feyerabend, T ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; DRUG DERIVATIVE; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; TAXOID;

ANIMAL; ARTICLE; BODY WEIGHT; DISEASE MODEL; DRUG EFFECT; FEMALE; HEAD AND NECK TUMOR; HUMAN; MOUSE; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PLATELETS; BODY WEIGHT; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE MODELS, ANIMAL; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; IFOSFAMIDE; METHOTREXATE; MICE; MICE, NUDE; PACLITAXEL; SURVIVAL RATE; TAXOIDS;

MLCS; MLOWN;

EID: 0035377046     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.18.6.1145     Document Type: Article

References (0)